IOL Chemicals & Pharmaceuticals

341.25
+9.30
(2.80%)
Market Cap
2,003.33 Cr
EPS
22.90
PE Ratio
20.10
Dividend Yield
1.50 %
Industry
Healthcare
52 Week High
537.70
52 Week low
327.40
PB Ratio
1.18
Debt to Equity
0.04
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
-3.56 %
Net Income Growth
-3.38 %
Cash Flow Change
137.25 %
ROE
-9.64 %
ROCE
-10.38 %
EBITDA Margin (Avg.)
7.59 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
579
570
547
530
596
570
552
529
511
510
532
527
Expenses
527
509
510
481
492
491
481
476
454
451
484
476
EBITDA
52
61
37
49
104
80
71
53
57
59
48
51
Operating Profit %
8 %
10 %
6 %
8 %
16 %
13 %
12 %
9 %
10 %
10 %
8 %
9 %
Depreciation
11
11
11
12
12
14
16
16
16
17
18
19
Interest
2
3
4
5
5
4
4
4
3
2
4
5
Profit Before Tax
39
47
22
33
87
61
51
32
37
40
26
28
Tax
9
12
6
9
22
15
13
9
10
10
7
7
Net Profit
30
35
16
24
65
46
38
23
28
30
19
21
EPS in ₹
5.07
5.91
2.71
4.05
11.03
7.81
6.45
3.93
4.71
5.11
3.26
3.50

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
1,962
2,022
2,244
Fixed Assets
561
752
933
Current Assets
1,081
920
1,120
Capital Work in Progress
105
90
101
Investments
2
20
20
Other Assets
1,294
1,161
1,190
Total Liabilities
1,962
2,022
2,244
Current Liabilities
513
456
560
Non Current Liabilities
57
58
73
Total Equity
1,392
1,508
1,612
Reserve & Surplus
1,334
1,449
1,553
Share Capital
59
59
59

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
-29
-2
6
Investing Activities
-121
-120
-191
Operating Activities
93
122
290
Financing Activities
-2
-4
-93

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
52.62 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.34 %
2.18 %
1.41 %
1.39 %
1.63 %
1.49 %
DIIs
0.04 %
0.04 %
0.36 %
0.50 %
0.02 %
0.02 %
0.06 %
0.17 %
0.02 %
0.26 %
0.36 %
0.37 %
0.30 %
0.10 %
0.08 %
0.08 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.30 %
28.03 %
29.86 %
30.15 %
30.29 %
31.15 %
31.15 %
30.92 %
30.49 %
29.28 %
30.28 %
30.63 %
30.98 %
31.48 %
31.31 %
31.23 %
Others
28.97 %
28.24 %
26.08 %
25.66 %
25.99 %
25.14 %
25.10 %
25.23 %
21.30 %
22.26 %
18.84 %
18.62 %
19.12 %
18.84 %
18.79 %
14.58 %
No of Share Holders
1,09,092
1,27,893
1,42,022
1,45,041
1,46,437
1,48,907
1,45,692
1,43,327
1,40,177
1,26,004
1,35,397
1,34,235
1,30,003
1,28,689
1,25,979
1,26,701

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 4 4 5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 1.41 1.11 1.51 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
6 days ago
Intimation On Communication To Members Regarding Tax Deduction At Source
6 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation
7 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release
8 days ago
Integrated Filing (Financial)
8 days ago
Corporate Action-Board approves Dividend
8 days ago
Board Meeting Outcome for Outcome Of The Board Meeting
8 days ago
Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2024
8 days ago
Corporate Action-Intimation of Sub division / Stock Split
Feb 07, 2025, 18:27
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 07, 2025, 16:29
Board Meeting Intimation for Notice Of The Board Meeting
Feb 04, 2025, 17:45
Intimation Of Amendment To The Memorandum Of Association Of The Company
Jan 31, 2025, 18:49
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Jan 31, 2025, 18:41
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Jan 31, 2025, 18:38
EDQM Issued CEP Certificate For MESALAZINE
Jan 17, 2025, 17:11
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 06, 2025, 16:34
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 02, 2025, 11:55
Board Comments On Fine Levied By The Exchange
Dec 27, 2024, 18:56
Board Meeting Outcome for Outcome Of The Board Meeting
Dec 27, 2024, 18:42
Closure of Trading Window
Dec 18, 2024, 16:33
Board Meeting Intimation for Notice Of The Board Meeting And Closure Of Trading Window
Dec 18, 2024, 16:27
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 18, 2024, 16:05

Technical Indicators